Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1984 Apr;81(7):2247–2251. doi: 10.1073/pnas.81.7.2247

Increase in the Bmax of gamma-aminobutyric acid-A recognition sites in brain regions of mice receiving diazepam.

P Ferrero, A Guidotti, E Costa
PMCID: PMC345475  PMID: 6326115

Abstract

gamma-Aminobutyric acid (GABA) receptors were characterized in vivo by studying ex vivo the binding of [3H]muscimol to cerebellum, cortex, hippocampus, and corpus striatum of mice receiving intravenous injections of tracer doses of high-specific-activity (approximately equal to 30 Ci/mmol) [3H]muscimol. This ligand binds with high affinity (apparent Kd, 2-3 X 10(-9) M) to a single population of binding sites (apparent Bmax, 250-180 fmol per 10 mg of protein). Pharmacological studies using drugs that selectively bind to GABAA or GABAB receptors suggest that [3H]muscimol specifically labels a GABAA recognition site. Moreover, diazepam (1.5 mumol/kg, i.p.) increases the Bmax but fails to change the affinity of [3H]muscimol binding to different brain areas. This diazepam-elicited increase in Bmax is blocked in mice receiving the diazepam antagonist Ro 15-1788 (ethyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5a]-[1,4] benzodiazepine-3-carboxylate). Since the diazepam-induced increase of [3H]muscimol binding is paralleled by a significant potentiation of the inhibitory effect of muscimol on locomotor activity, it is proposed that the facilitatory action on GABAergic transmission elicited in vivo by diazepam is mediated by an increase in the Bmax of the binding sites of GABAA receptors.

Full text

PDF
2247

Images in this article

2249Image
on p.2249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAXTER C. F., ROBERTS E. Elevation of gamma-aminobutyric acid in brain: selective inhibition of gamma-aminobutyric-alpha-ketoglutaric acid transaminase. J Biol Chem. 1961 Dec;236:3287–3294. [PubMed] [Google Scholar]
  2. Baraldi M., Grandison L., Guidotti A. Distribution and metabolism of muscimol in the brain and other tissues of the rat. Neuropharmacology. 1979 Jan;18(1):57–62. doi: 10.1016/0028-3908(79)90009-1. [DOI] [PubMed] [Google Scholar]
  3. Bowery N. G., Hill D. R., Hudson A. L., Doble A., Middlemiss D. N., Shaw J., Turnbull M. (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature. 1980 Jan 3;283(5742):92–94. doi: 10.1038/283092a0. [DOI] [PubMed] [Google Scholar]
  4. Braestrup C., Schmiechen R., Neef G., Nielsen M., Petersen E. N. Interaction of convulsive ligands with benzodiazepine receptors. Science. 1982 Jun 11;216(4551):1241–1243. doi: 10.1126/science.6281892. [DOI] [PubMed] [Google Scholar]
  5. Chang R. S., Snyder S. H. Benzodiazepine receptors: labeling in intact animals with [3H] flunitrazepam. Eur J Pharmacol. 1978 Mar 15;48(2):213–218. doi: 10.1016/0014-2999(78)90330-8. [DOI] [PubMed] [Google Scholar]
  6. Costa E., Guidotti A. Molecular mechanisms in the receptor action of benzodiazepines. Annu Rev Pharmacol Toxicol. 1979;19:531–545. doi: 10.1146/annurev.pa.19.040179.002531. [DOI] [PubMed] [Google Scholar]
  7. Glowinski J., Iversen L. L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem. 1966 Aug;13(8):655–669. doi: 10.1111/j.1471-4159.1966.tb09873.x. [DOI] [PubMed] [Google Scholar]
  8. Guidotti A., Gale K., Suria A., Toffano G. Biochemical evidence for two classes of GABA receptors in rat brain. Brain Res. 1979 Aug 31;172(3):566–571. doi: 10.1016/0006-8993(79)90590-0. [DOI] [PubMed] [Google Scholar]
  9. Guidotti A., Konkel D. R., Ebstein B., Corda M. G., Wise B. C., Krutzsch H., Meek J. L., Costa E. Isolation, characterization, and purification to homogeneity of a rat brain protein (GABA-modulin). Proc Natl Acad Sci U S A. 1982 Oct;79(19):6084–6088. doi: 10.1073/pnas.79.19.6084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guidotti A., Toffano G., Costa E. An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in rat brain. Nature. 1978 Oct 12;275(5680):553–555. doi: 10.1038/275553a0. [DOI] [PubMed] [Google Scholar]
  11. Hunkeler W., Möhler H., Pieri L., Polc P., Bonetti E. P., Cumin R., Schaffner R., Haefely W. Selective antagonists of benzodiazepines. Nature. 1981 Apr 9;290(5806):514–516. doi: 10.1038/290514a0. [DOI] [PubMed] [Google Scholar]
  12. Ito Y., Kuriyama K. Some properties of solubilized GABA receptor. Brain Res. 1982 Mar 25;236(2):351–364. doi: 10.1016/0006-8993(82)90720-x. [DOI] [PubMed] [Google Scholar]
  13. Krogsgaard-Larsen P., Johnston G. A., Lodge D., Curtis D. R. A new class of GABA agonist. Nature. 1977 Jul 7;268(5615):53–55. doi: 10.1038/268053a0. [DOI] [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Laduron P. M., Janssen P. F., Leysen J. E. Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs. Biochem Pharmacol. 1978 Feb 1;27(3):317–321. doi: 10.1016/0006-2952(78)90234-4. [DOI] [PubMed] [Google Scholar]
  16. Moroni F., Forchetti M. C., Krogsgaard-Larsen P., Guidotti A. Relative disposition of the GABA agonists THIP and muscimol in the brain of the rat. J Pharm Pharmacol. 1982 Oct;34(10):676–678. doi: 10.1111/j.2042-7158.1982.tb04702.x. [DOI] [PubMed] [Google Scholar]
  17. Möhler H., Richards J. G. Agonist and antagonist benzodiazepine receptor interaction in vitro. Nature. 1981 Dec 24;294(5843):763–765. doi: 10.1038/294763a0. [DOI] [PubMed] [Google Scholar]
  18. Pert C. B., Snyder S. H. Identification of opiate receptor binding in intact animals. Life Sci. 1975 May 15;16(10):1623–1634. doi: 10.1016/0024-3205(75)90080-6. [DOI] [PubMed] [Google Scholar]
  19. Schmid R., Hong J. S., Meek J., Costa E. The effect of kainic acid on the hippocampal content of putative transmitter amino acids. Brain Res. 1980 Nov 3;200(2):355–362. doi: 10.1016/0006-8993(80)90926-9. [DOI] [PubMed] [Google Scholar]
  20. Skerritt J. H., Willow M., Johnston G. A. Diazepam enhancement of low affinity GABA binding to rat brain membranes. Neurosci Lett. 1982 Mar 17;29(1):63–66. doi: 10.1016/0304-3940(82)90365-2. [DOI] [PubMed] [Google Scholar]
  21. Tallman J. F., Thomas J. W., Gallager D. W. GABAergic modulation of benzodiazepine binding site sensitivity. Nature. 1978 Jul 27;274(5669):383–385. doi: 10.1038/274383a0. [DOI] [PubMed] [Google Scholar]
  22. Wise B. C., Guidotti A., Costa E. Phosphorylation induces a decrease in the biological activity of the protein inhibitor (GABA-modulin) of gamma-aminobutyric acid binding sites. Proc Natl Acad Sci U S A. 1983 Feb;80(3):886–890. doi: 10.1073/pnas.80.3.886. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES